Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    The Use of Intracerebral Microdialysis to Determine Changes in Blood-Brain Barrier Transport Characteristics

    The aim of this study was to determine whether changes in the transport of drugs into the brain could be determined by in vivo intracerebral microdialysis. Atenolol was used as a model drug to determine blood-...

    Elizabeth C. M. de Lange, Mayke B. Hesselink, Meindert Danhof in Pharmaceutical Research (1995)

  2. No Access

    Article

    Drug Equilibration Across the Blood—Brain Barrier-Pharmacokinetic Considerations Based on the Microdialysis Method

    Purpose. The purpose of the study was to investigate the influence of different rates of transport into and out of the brain, including passive and active transport, on unbound brain concentrations and profile i...

    Margareta Hammarlund-Udenaes, Lennart K. Paalzow in Pharmaceutical Research (1997)

  3. No Access

    Article

    BBB Transport and P-glycoprotein Functionality Using MDR1A (-/-) and Wild-Type Mice. Total Brain Versus Microdialysis Concentration Profiles of Rhodamine-123

    Purpose. The effect of P-glycoprotein (Pgp) on brain distribution using mdrla (-/-) mice was investigated.

    Elizabeth C. M. de Lange, Gertjan de Bock, Alfred H. Schinkel in Pharmaceutical Research (1998)

  4. No Access

    Article

    Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling

    Our ultimate goal is to develop mechanism-based pharmacokinetic (PK)-pharmacodynamic (PD) models to characterize and to predict CNS drug responses in both physiologic and pathologic conditions. To this end, it...

    Elizabeth C. M. de Lange, Paulien G. M. Ravenstijn, Dorien Groenendaal in The AAPS Journal (2005)

  5. Article

    Open Access

    A New Minimal-Stress Freely-Moving Rat Model for Preclinical Studies on Intranasal Administration of CNS Drugs

    To develop a new minimal-stress model for intranasal administration in freely moving rats and to evaluate in this model the brain distribution of acetaminophen following intranasal versus intravenous administrati...

    Jasper Stevens, Ernst Suidgeest, Piet Hein van der Graaf in Pharmaceutical Research (2009)

  6. Article

    Open Access

    Physiologically Based Pharmacokinetic Modeling to Investigate Regional Brain Distribution Kinetics in Rats

    One of the major challenges in the development of central nervous system (CNS)-targeted drugs is predicting CNS exposure in human from preclinical data. In this study, we present a methodology to investigate b...

    Joost Westerhout, Bart Ploeger, Jean Smeets, Meindert Danhof in The AAPS Journal (2012)

  7. No Access

    Article

    Mechanism-based PK–PD model for the prolactin biological system response following an acute dopamine inhibition challenge: quantitative extrapolation to humans

    The aim of this investigation was to develop a mechanism-based pharmacokinetic–pharmacodynamic (PK–PD) model for the biological system prolactin response following a dopamine inhibition challenge using remoxip...

    Jasper Stevens, Bart A. Ploeger in Journal of Pharmacokinetics and Pharmacody… (2012)

  8. Article

    Open Access

    Utility of CSF in translational neuroscience

    Human cerebrospinal fluid (CSF) sampling is of high value as the only general applicable methodology to obtain information on free drug concentrations in individual human brain. As the ultimate interest is in ...

    Elizabeth C. M. de Lange in Journal of Pharmacokinetics and Pharmacodynamics (2013)

  9. Article

    Open Access

    The impact of P-gp functionality on non-steady state relationships between CSF and brain extracellular fluid

    In the development of central nervous system (CNS)-targeted drugs, the prediction of human CNS target exposure is a big challenge. Cerebrospinal fluid (CSF) concentrations have often been suggested as a ‘good ...

    Joost Westerhout, Jean Smeets in Journal of Pharmacokinetics and Pharmacody… (2013)

  10. Article

    Open Access

    Diurnal Variation in P-glycoprotein-Mediated Transport and Cerebrospinal Fluid Turnover in the Brain

    Nearly all bodily processes exhibit circadian rhythmicity. As a consequence, the pharmacokinetic and pharmacodynamic properties of a drug may also vary with time of day. The objective of this study was to inve...

    Laura Kervezee, Robin Hartman, Dirk-Jan van den Berg, Shinji Shimizu in The AAPS Journal (2014)

  11. Article

    Open Access

    Emerging Insights for Translational Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Studies: Towards Prediction of Nose-to-Brain Transport in Humans

    To investigate the potential added value of intranasal drug administration, preclinical studies to date have typically used the area under the curve (AUC) in brain tissue or cerebrospinal fluid (CSF) compared ...

    Mitchel J. R. Ruigrok, Elizabeth C. M. de Lange in The AAPS Journal (2015)

  12. Article

    Open Access

    A Generic Multi-Compartmental CNS Distribution Model Structure for 9 Drugs Allows Prediction of Human Brain Target Site Concentrations

    Predicting target site drug concentration in the brain is of key importance for the successful development of drugs acting on the central nervous system. We propose a generic mathematical model to describe the...

    Yumi Yamamoto, Pyry A. Välitalo, Dirk-Jan van den Berg in Pharmaceutical Research (2017)

  13. Article

    Erratum to: Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations

    Yumi Yamamoto, Meindert Danhof, Elizabeth C. M. de Lange in The AAPS Journal (2017)

  14. Article

    Open Access

    Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations

    Despite the enormous research efforts that have been put into the development of central nervous system (CNS) drugs, the success rate in this area is still disappointing. To increase the successful rate in the...

    Yumi Yamamoto, Meindert Danhof, Elizabeth C. M. de Lange in The AAPS Journal (2017)

  15. Article

    Open Access

    Target and Tissue Selectivity Prediction by Integrated Mechanistic Pharmacokinetic-Target Binding and Quantitative Structure Activity Modeling

    Selectivity is an important attribute of effective and safe drugs, and prediction of in vivo target and tissue selectivity would likely improve drug development success rates. However, a lack of understanding of ...

    Anna H. C. Vlot, Wilhelmus E. A. de Witte, Meindert Danhof in The AAPS Journal (2017)

  16. Article

    Open Access

    Modelling the delay between pharmacokinetics and EEG effects of morphine in rats: binding kinetic versus effect compartment models

    Drug–target binding kinetics (as determined by association and dissociation rate constants, kon and koff) can be an important determinant of the kinetics of drug action. However, the effect compartment model is u...

    Wilhelmus E. A. de Witte, Vivi Rottschäfer in Journal of Pharmacokinetics and Pharmacody… (2018)

  17. Article

    Open Access

    Correction to: Modelling the delay between pharmacokinetics and EEG effects of morphine in rats: binding kinetic versus effect compartment models

    The original version of this article was published open access. Unfortunately, due to a technical issue, the copyright holder name in the online version (HTML and XML) is incorrectly published as “Springer Sci...

    Wilhelmus E. A. de Witte, Vivi Rottschäfer in Journal of Pharmacokinetics and Pharmacody… (2018)

  18. No Access

    Article

    Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity

    Available data on human brain P-glycoprotein ontogeny during infancy and childhood are limited. This review discusses the current body of data relating to maturation of human brain P-glycoprotein including tra...

    Jean-Marie Nicolas, Elizabeth C. M. de Lange in The AAPS Journal (2019)

  19. Article

    Open Access

    The 3D Brain Unit Network Model to Study Spatial Brain Drug Exposure under Healthy and Pathological Conditions

    We have developed a 3D brain unit network model to understand the spatial-temporal distribution of a drug within the brain under different (normal and disease) conditions. Our main aim is to study the impact o...

    Esmée Vendel, Vivi Rottschäfer, Elizabeth C.M. de Lange in Pharmaceutical Research (2020)

  20. Article

    Open Access

    Lumbar cerebrospinal fluid-to-brain extracellular fluid surrogacy is context-specific: insights from LeiCNS-PK3.0 simulations

    Predicting brain pharmacokinetics is critical for central nervous system (CNS) drug development yet difficult due to ethical restrictions of human brain sampling. CNS pharmacokinetic (PK) profiles are often al...

    Mohammed A. A. Saleh, Chi Fong Loo in Journal of Pharmacokinetics and Pharmacody… (2021)

previous disabled Page of 2